Researcher
Hendrik Everaert
- Keywords:Medicine
- Disciplines:Nuclear imaging
Affiliations
- Medical Imaging (Research group)
Member
From1 Jan 2011 → Today - Nuclear Medicine (Department)
Member
From1 Jan 2008 → Today - Supporting clinical sciences (Department)
Member
From1 Jan 2024 → Today - Supporting clinical sciences (Department)
Member
From8 Apr 2019 → 28 Feb 2023 - Supporting clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Medical Imaging and Physical Sciences (Department)
Member
From1 Mar 2010 → 31 Dec 2013 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2002 → 30 Sep 2010
Projects
1 - 1 of 1
- Image-guided stereotactic radiotherapy for dose escalation in inoperable stage I/II non-small cell lung cancer with selective application of breathing synchronisation with audiovisual feedback.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 80
- Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma(2024)
Authors: Odrade Gondry, Vicky Caveliers, Catarina Xavier, Marian Vanhoeij, Guy Verfaillie, C Fontaine, Katrien Glorieus, Jacques De Grève, S Joris, Ine Luyten, et al.
Pages: 178-184 - Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Authors: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, C Fontaine, et al.
Pages: 1378-1384 - Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer(2023)
Authors: Benedikt Engels, Antonino De Paoli, Elena Delmastro, Fernando Munoz, Stefano Vagge, Darius Norkus, Hendrik Everaert, Gianna Tabaro, Elisabetta Gariboldi, Umberto Ricardi, et al.
- Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series(2023)
Authors: Jens Tijtgat, Iris Dirven, Manon Vounckx, Randa Kamel, Anne-Marie Van Binst, Hendrik Everaert, Laura Seynaeve, Dirk Van Den Berge, Johnny Duerinck, Bart Neyns
- Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer?(2022)
Authors: Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert
Pages: 287-302 - INTRA-CRANIAL ADMINISTRATION OF CTLA-4 AND PD-1 IMMUNE CHECKPOINT-INHIBITING MONOCLONAL ANTIBODIES IN RECURRENT GLIOBLASTOMA PATIENTS: A MULTI-COHORT ADAPTIVE PHASE I CLINICAL TRIAL(2021)
Authors: Johnny Duerinck, Wietse Geens, Julia Katharina Schwarze, Cleo Bertels, Jens Tijtgat, Gil Awada, Freya Vaeyens, Louise Cras, Lynn Nijland, Anne-Marie Van Binst, et al.
Pages: 53-53 - The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression(2021)
Authors: Karolien Vekens, Hendrik Everaert, Bart Neyns, Bart Ilsen, Lore Decoster
Pages: 432-440 - Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, C Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio(2021)
Authors: Vincent Vinh-Hung, Hendrik Everaert, Olena Gorobets, Hilde Van Parijs, Guy Verfaillie, Marian Vanhoeij, Guy Storme, C Fontaine, Jan Lamote, Justine Perrin, et al.
Pages: 956-968 - Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma(2021)
Authors: Johnny Duerinck, Julia Katharina Schwarze, Gil Awada, Jens Tijtgat, Freya Vaeyens, Cleo Bertels, Wietse Geens, Samuel Klein, Laura Seynaeve, Louise Cras, et al.